Women’s Health Market Share, Size, Trends, Industry Analysis Report By Treatment Type, By Disease type, By Geography, Segments and Forecast 2014 - 2025

Women’s health is a viewpoint of treatment and prevention that emphasizes at health concerns distinctive to females. Medical research traditionally has neglected the common health needs of women, other than reproductive concerns. Women’s well-being and health is a function of biological factors and it differs in both men and women, which is affected by social and public aspects.

Currently, there have been major changes in private and government support of women’s health research with respect to regulations, the organization, and policies of research efforts. The women’s health research has contributed to major progress over the past 2 decades in diminishing the occurrence of diseases and reducing death cases in women. Improved women’s health has helped in research areas and in the solicitation of results to benefit women in general and globally across multiple population groups. There has been insufficient attention paid to the environmental and social factors that improve women’s health. Though, progress has been made in recognizing behavioural factors of women’s health, such as diet, smoking, and physical activity. Recently, studies have been established to transform these factors in women that affect social and community dynamics in specific groups of women.

Increasing preference towards a healthy lifestyle and high adoption of diagnostics imaging procedures enhances the global market growth.

Global women’s health market is driven by multiple factors including growing number of menopausal conditions amongst women. Also, change in lifestyles and poor dietary habits are factors expected to make a significant growth of the overall market. According to World Health Organization (WHO), in 2014, around 13.3% of women over 18 years were in fair or poor health condition. In addition, demand for point of care diagnostic testing, increase in the incidence of chronic disorders such as cancer and cardiac ailments, high adoption of diagnostics imaging procedures, and increase in old age female population are another factors anticipated to bolster the global market. Moreover, numerous government initiatives to promote women health awareness also drives the market growth. According to International Osteoporosis Foundation (IOF) report, by 2050, 42% of women over 50 years will experience osteoporosis fractures due to lack of calcium and phosphate. Thus, awareness programs to diminish such conditions also positively impacts the global market. Growing spending on developing a healthy healthcare infrastructure has successfully made a rapid growth in health awareness among women. Furthermore, various government and private firms have taken up initiatives with respect to women’s health through women care programs.

Increasing awareness regarding the fertility in emerging economies fuel the global market growth

The government ingenuity for awareness about the fertility in emerging countries such as Japan, China, and India to limit the population evolution is anticipated to bolster the women healthcare market in the forecast period. Whereas in developed economies such as the U.S. and Canada, most women do not use contraceptive medication due to side effects such as dysmenorrhea, menorrhagia, hirsutism, endometriosis, alopecia, and premenstrual syndrome. This has augmented the use of IUDs and scions. Thus, increasing awareness about alternate methods is also expected to fuel the global market growth.

Demand for the development of miniature diagnostic devices and rise in healthcare infrastructure mainly in emerging economies are expected to provide significant opportunities for the market growth during the forecast period.

However, high cost of diagnostics tests and lack of skilled professionals hampers the global market growth.

Global Women’s Health Market Taxonomy

The global women’s health market is segmented on the basis of treatment type, disease type and geography.

On the basis of treatment type, the global women’s health is segmented into:

• Hormonal Treatment
  
  • Estrogen Therapy
  • Progestin Therapy
  • Combination Therapy
  • Thyroid Replacement Therapy
  • Parathyroid Hormone Therapy
  • Others
• Non-Hormonal Treatment
  
  • Targeted Therapy Drugs
  • Antibiotics
  • Bisphosphonates
  • Others

On the basis of disease type, the global women’s health is segmented into:

• Cancer
  
  • Breast Cancer
  • Cervical Cancer
  • Ovarian Cancer
• Hypothyroidism
• Post-Menopausal Syndrome
• Osteoporosis
• Contraceptive
• Uterine Fibroid
• Urinary Tract Infection
• Others

Geographically, the global women’s health market is segmented into North America, Europe, Asia pacific, Latin America, Middle East, and Africa.

The Asia Pacific showing remarkable market growth due to presence of high population and government initiatives

On the basis of geography, North America is estimated to dominate the global market. Increasing geriatric population in this region is one of the key factors boosting demand for women’s health market in North America. At present around 15% of the female population of North America is aged above 65 years, and they experience several and emotional as well as physiological issues due to hormonal changes in their body. Thus, such high number of old age women are anticipated to boost the market in this region. Furthermore, high health care spending and rise in inclination for using biologics and its related substitutes in women are other key factors that attributed to the dominance of this region.

Asia Pacific region is expected to make a remarkable growth during the forecast period owing to increasing demand for contraceptives and large population present in this region. Increase in government resourcefulness and initiatives in developing economies such as India, China, and Bangladesh to limit population growth is anticipated to enhance the women’s health market in this region.

Major key players in the Global Women’s Health market

• Amgen, Inc.
• AstraZeneca
• Bristol-Myers Squibb Company
• Merck & Co., Inc.
• Allergan
• Pfizer, Inc.
• Teva Pharmaceutical Industries Ltd.
• Bayer AG
• Ferring B.V.